Eli Lilly & Co.’s blockbuster obesity shot Zepbound helped people with type 1 diabetes lose more than a fifth of their body ...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis.

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Many GLP-1 users suddenly discover they don't have as much "food noise" or constant thoughts about eating anymore. They also ...

“It is not one-size-fits-all, and every medication can have risks and side effects,” Mao added in a university news release. ...

More research is needed to understand why the drug works better for women Get any of our free email newsletters — news ...

Although women lost more weight, all participants saw significant decreases in total body weight on all doses of the medication.

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

Most trillion-dollar companies today are in the technology sector, but one particular healthcare stock is knocking on the door of a trillion-dollar valuation.

Results from 4 studies revealed that women lost more weight on average than men when taking tirzepatide — but they also ...

Millions turn to compounded versions of popular weight loss drugs amid shortages and high costs.